Remiges Ventures
2023.03.31Capacity Bio, For Which Remiges Ventures Was Founding Investor, Raised $35M
2023.01.04Remiges Portfolio Companies Raised In Aggregate More Than $145 million in 2022
2022.12.23Immunohelix Co., Ltd, one of our portfolio companies, was selected for AMED Strengthening Program for Pharmaceutical Venture Ecosystem
2022.09.26Remiges Ventures led the Series A round of finance for Kupando GmbH in Germany
2022.06.30Remiges selected as Certified VC by the AMED Strengthening Program for Pharmaceutical Venture Ecosystem
2022.06.06Luca Science, one of our portfolio companies in Japan, closed a $30.3M Series B round
